Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 3049-3051

  Witkowski, Benoit ^a,b,c   Nicolau, Marie Laure ^a,b,c   Soh, Patrice Njomnang ^a,b,c   Iriart, Xavier ^a,b   Menard, Sandie ^a,b   Alvarez, Muriel ^a   Marchou, Bruno ^a   Magnaval, Jean François ^a,b   Benoit Vical, Françoise ^a,b,c   Berry, Antoine ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; BETA TUBULIN; DNA; MEFLOQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN;

AFRICA; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; COPY NUMBER VARIATION; DRUG EFFICACY; DUPLICATE GENE; GENE AMPLIFICATION; GENOTYPE; HUMAN; MALARIA FALCIPARUM; NONHUMAN; PFMDR1; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; DRUG EFFECTS; GENE DOSAGE; GENETICS; MALARIA, FALCIPARUM; PARASITOLOGY; PATHOGENICITY;

AFRICA; ANIMALS; ANTIMALARIALS; ARTEMISININS; GENE DOSAGE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM;

EID: 77953745485     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00209-10     Document Type: Article

References (16)

1. Basco, L. K., J. Le Bras, Z. Rhoades, and C. M. Wilson. 1995. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol. Biochem. Parasitol. 74:157-166.
2. Begum, K., H. S. Kim, Y. Okuda, Y. Wataya, M. Kimura, and T. Huruta. 2002. Genomic analysis of mefloquine-resistant Plasmodium falciparum. Nucleic Acids Res. 2002(Suppl. 2):223-224.
3. Briand, V., J. Bottero, H. Noel, V. Masse, H. Cordel, J. Guerra, H. Kossou, B. Fayomi, P. Ayemonna, N. Fievet, A. Massougbodji, and M. Cot. 2009. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxinepyrimethamine with mefloquine. J. Infect. Dis. 200:991-1001.
4. Carrara, V. I., J. Zwang, E. A. Ashley, R. N. Price, K. Stepniewska, M. Barends, A. Brockman, T. Anderson, R. McGready, L. Phaiphun, S. Proux, M. van Vugt, R. Hutagalung, K. M. Lwin, A. P. Phyo, P. Preechapornkul, M. Imwong, S. Pukrittayakamee, P. Singhasivanon, N. J. White, and F. Nosten. 2009. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4:e4551.
5. Gay, F., M. H. Binet, M. D. Bustos, B. Rouveix, M. Danis, C. Roy, and M. Gentilini. 1990. Mefloquine failure in child contracting falciparum malaria in West Africa. Lancet 335:120-121.
6. Happi, C. T., G. O. Gbotosho, O. A. Folarin, A. Sowunmi, T. Hudson, M. O'Neil, W. Milhous, D. F. Wirth, and A. M. Oduola. 2009. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 53:888-895.
7. Holmgren, G., A. Bjorkman, and J. P. Gil. 2006. Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya. Trop. Med. Int. Health 11:1808-1812.
8. Lim, P., A. P. Alker, N. Khim, N. K. Shah, S. Incardona, S. Doung, P. Yi, D. M. Bouth, C. Bouchier, O. M. Puijalon, S. R. Meshnick, C. Wongsrichanalai, T. Fandeur, J. Le Bras, P. Ringwald, and F. Ariey. 2009. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 8:11.
9. Meremikwu, M., U. Okomo, C. Nwachukwu, A. Oyo-Ita, J. Eke-Njoku, J. Okebe, E. Oyo-Ita, and P. Garner. 2007. Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study. Malar. J. 6:55.
10. Oduola, A. M., W. K. Milhous, L. A. Salako, O. Walker, and R. E. Desjardins. 1987. Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet ii:1304-1305.
11. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
12. Sibley, C. H., P. J. Guerin, and P. Ringwald. 20 March 2010. Monitoring antimalarial resistance: launching a cooperative effort. Trends Parasitol. [Epub ahead of print]. doi:10.1016/j.pt.2010.02.008.
13. Sidhu, A. B., A. C. Uhlemann, S. G. Valderramos, J. C. Valderramos, S. Krishna, and D. A. Fidock. 2006. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194:528-535.
14. Sowunmi, A., and L. A. Salako. 1992. Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria. Ann. Trop. Med. Parasitol. 86:1-8.
15. Uhlemann, A. C., M. Ramharter, B. Lell, P. G. Kremsner, and S. Krishna. 2005. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J. Infect. Dis. 192:1830-1835.
16. Ursing, J., P. E. Kofoed, L. Rombo, and J. P. Gil. 2006. No pfmdr1 amplifications in samples from Guinea-Bissau and Liberia collected between 1981 and 2004. J. Infect. Dis. 194:716-719.